{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:56:47Z","timestamp":1790146607679,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"scientific research area of the Sichuan provincial health and family planning commission","award":["150097"],"award-info":[{"award-number":["150097"]}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jcyt.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T02:00:10Z","timestamp":1460253610000},"page":"712-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Safety and efficacy of cell-based therapy on critical limb ischemia: A meta-analysis"],"prefix":"10.1016","volume":"18","author":[{"given":"Min","family":"Ai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Fu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Chun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcyt.2016.02.009_bib0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5114\/aoms.2012.28568","article-title":"Peripheral arterial disease of the lower extremities","volume":"8","author":"Aronow","year":"2012","journal-title":"Arch Med Sci"},{"issue":"2","key":"10.1016\/j.jcyt.2016.02.009_bib0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5114\/aoms.2013.39935","article-title":"Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia","volume":"11","author":"Skora","year":"2015","journal-title":"Arch Med Sci"},{"issue":"9","key":"10.1016\/j.jcyt.2016.02.009_bib0020","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.114.303505","article-title":"Pharmacological treatment and current management of peripheral artery disease","volume":"116","author":"Bonaca","year":"2015","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.jcyt.2016.02.009_bib0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00045415-200107000-00010","article-title":"Medical management of peripheral arterial disease","volume":"9","author":"Creager","year":"2001","journal-title":"Cardiol Rev"},{"issue":"4","key":"10.1016\/j.jcyt.2016.02.009_bib0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.suc.2013.04.009","article-title":"Contemporary and optimal medical management of peripheral arterial disease","volume":"93","author":"Tattersall","year":"2013","journal-title":"Surg Clin North Am"},{"issue":"6","key":"10.1016\/j.jcyt.2016.02.009_bib0035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.5114\/aoms.2013.39630","article-title":"Surgical treatment of lower limb ischemia in diabetic patients\u2014long-term results","volume":"9","author":"Inan","year":"2013","journal-title":"Arch Med Sci"},{"issue":"3","key":"10.1016\/j.jcyt.2016.02.009_bib0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/dth.12207","article-title":"Treatment of thromboangiitis obliterans (Buerger's disease) with high-potency vasodilators","volume":"28","author":"Jimenez-Gallo","year":"2015","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jcyt.2016.02.009_bib0045","first-page":"156905","article-title":"Thromboangiitis obliterans (Buerger's disease)\u2014current practices","volume":"2013","author":"Vijayakumar","year":"2013","journal-title":"Int J Inflam"},{"issue":"3","key":"10.1016\/j.jcyt.2016.02.009_bib0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jvs.2012.08.115","article-title":"Predictors and outcomes of restenosis following tibial artery endovascular interventions for critical limb ischemia","volume":"57","author":"Saqib","year":"2013","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.1016\/j.jcyt.2016.02.009_bib0055","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1078-5884(98)80032-4","article-title":"Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group","volume":"15","author":"Anon.","year":"1998","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"9331","key":"10.1016\/j.jcyt.2016.02.009_bib0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.jcyt.2016.02.009_bib0065","first-page":"4296","article-title":"Autologous bone marrow stem cell transplantation in critical limb ischemia: a meta-analysis of randomized controlled trials","volume":"125","author":"Liu","year":"2012","journal-title":"Chin Med J"},{"issue":"6","key":"10.1016\/j.jcyt.2016.02.009_bib0070","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.jcyt.2016.02.009_bib0075","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.5551\/jat.23374","article-title":"Efficacy of autologous bone marrow mononuclear cell therapy in patients with peripheral arterial disease","volume":"21","author":"Wang","year":"2014","journal-title":"J Atheroscler Thromb"},{"issue":"12","key":"10.1016\/j.jcyt.2016.02.009_bib0080","article-title":"Dolmatova E. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia","author":"Moazzami","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jcyt.2016.02.009_bib0085","doi-asserted-by":"crossref","first-page":"e0125032","DOI":"10.1371\/journal.pone.0125032","article-title":"Therapeutic efficacy of stem cell-based therapy in peripheral arterial disease: a meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2016.02.009_bib0090","article-title":"Cell therapy for critical limb ischemia: a meta-analysis of randomized controlled trials","author":"Liew","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.jcyt.2016.02.009_bib0095","series-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","author":"Higgins","year":"2011"},{"issue":"6","key":"10.1016\/j.jcyt.2016.02.009_bib0100","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/add.12788","volume":"110","author":"Davoli","year":"2015","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.jcyt.2016.02.009_bib0105","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","article-title":"Methods for trend estimation from summarized dose-response data, with applications to meta-analysis","volume":"135","author":"Greenland","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jcyt.2016.02.009_bib0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1536867X0600600103","article-title":"Generalized least squares for trend estimation of summarized dose-response data","volume":"6","author":"Orsini","year":"2006","journal-title":"Stata J"},{"issue":"1","key":"10.1016\/j.jcyt.2016.02.009_bib0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/aje\/kwr265","article-title":"Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software","volume":"175","author":"Orsini","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.jcyt.2016.02.009_bib0120","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3945\/ajcn.112.052449","article-title":"Dietary calcium intake and risk of stroke: a dose-response meta-analysis","volume":"97","author":"Larsson","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.jcyt.2016.02.009_bib0125","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.jcyt.2016.02.009_bib0130","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes","volume":"28","author":"Huang","year":"2005","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.jcyt.2016.02.009_bib0135","first-page":"1005","article-title":"Observation on therapeutic effect of autologous bone marrow stem cell transplantation for diabetes patients complicated with lower limb ischemia","volume":"19","author":"Chen","year":"2005","journal-title":"Chin Nurs Res"},{"issue":"9","key":"10.1016\/j.jcyt.2016.02.009_bib0140","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1253\/circj.70.1093","article-title":"Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease","volume":"70","author":"Arai","year":"2006","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.jcyt.2016.02.009_bib0145","first-page":"155","article-title":"Bone-marrow cells in therapy of critical limb ischemia of lower extremities\u2014own experience","volume":"12","author":"Bar\u0107","year":"2006","journal-title":"Acta Angiol"},{"issue":"12","key":"10.1016\/j.jcyt.2016.02.009_bib0150","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00392-007-0569-x","article-title":"Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study)","volume":"96","author":"Bartsch","year":"2007","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"10.1016\/j.jcyt.2016.02.009_bib0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/bmt.2008.228","article-title":"Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease","volume":"42","author":"Cobellis","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2016.02.009_bib0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1000-1948(08)60031-3","article-title":"Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia","volume":"23","author":"Lu","year":"2008","journal-title":"J Med Coll PLA"},{"issue":"5","key":"10.1016\/j.jcyt.2016.02.009_bib0165","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/rej.2009.0872","article-title":"Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells","volume":"12","author":"Dash","year":"2009","journal-title":"Rejuvenation Res"},{"issue":"11","key":"10.1016\/j.jcyt.2016.02.009_bib0170","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3727\/096368910X514170","article-title":"Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer","volume":"19","author":"Prochazka","year":"2010","journal-title":"Cell Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2016.02.009_bib0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCINTERVENTIONS.110.958348","article-title":"Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA)","volume":"4","author":"Walter","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.jcyt.2016.02.009_bib0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCINTERVENTIONS.110.955724","article-title":"Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease","volume":"4","author":"Idei","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.jcyt.2016.02.009_bib0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial","volume":"92","author":"Lu","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.jcyt.2016.02.009_bib0190","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jvs.2011.04.006","article-title":"Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia","volume":"54","author":"Powell","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jcyt.2016.02.009_bib0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1479-5876-9-165","article-title":"The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design","volume":"9","author":"Benoit","year":"2011","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2016.02.009_bib0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jdiacomp.2011.11.007","article-title":"Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia","volume":"26","author":"Ozturk","year":"2012","journal-title":"J Diabetes Complications"},{"issue":"6","key":"10.1016\/j.jcyt.2016.02.009_bib0205","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/mt.2012.52","article-title":"Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial","volume":"20","author":"Powell","year":"2012","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.jcyt.2016.02.009_bib0210","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCINTERVENTIONS.112.968321","article-title":"A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia","volume":"5","author":"Losordo","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.jcyt.2016.02.009_bib0215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/s-0032-1311646","article-title":"Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia","volume":"121","author":"Mohammadzadeh","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"10.1016\/j.jcyt.2016.02.009_bib0220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.6002\/ect.2012.0129","article-title":"Autologous bone marrow mononuclear cells transplant in patients with critical leg ischemia: preliminary clinical results","volume":"11","author":"Li","year":"2013","journal-title":"Exp Clin Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2016.02.009_bib0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/dmrr.2399","article-title":"Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment","volume":"29","author":"Dubsky","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jcyt.2016.02.009_bib0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1479-5876-11-143","article-title":"A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia","volume":"11","author":"Gupta","year":"2013","journal-title":"J Transl Med"},{"issue":"10","key":"10.1016\/j.jcyt.2016.02.009_bib0235","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jcyt.2013.05.017","article-title":"Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up","volume":"15","author":"Szabo","year":"2013","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1016\/j.jcyt.2016.02.009_bib0240","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.jcyt.2014.07.011","article-title":"Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial","volume":"16","author":"Raval","year":"2014","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1016\/j.jcyt.2016.02.009_bib0245","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jcyt.2016.02.009_bib0250","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jvs.2013.01.037","article-title":"Transplantation of purified CD34+ cells in the treatment of critical limb ischemia","volume":"58","author":"Dong","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jcyt.2016.02.009_bib0255","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbmt.2014.10.007","article-title":"Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis","volume":"21","author":"Hsu","year":"2015","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324916300032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324916300032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:22:52Z","timestamp":1761430972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324916300032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1465324916300032"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2016.02.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of cell-based therapy on critical limb ischemia: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}